Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 750

1.

Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?

Burton CM, Iversen M, Mortensen J, Carlsen J, Andersen CB, Milman N, Scheike T.

J Heart Lung Transplant. 2007 Nov;26(11):1127-34. Epub 2007 Sep 29.

PMID:
18022078
2.

Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.

Burton CM, Iversen M, Carlsen J, Mortensen J, Andersen CB, Steinbrüchel D, Scheike T.

J Heart Lung Transplant. 2009 Sep;28(9):888-93. doi: 10.1016/j.healun.2009.04.022.

PMID:
19716040
3.

Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.

Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J.

J Heart Lung Transplant. 1998 Dec;17(12):1255-63.

PMID:
9883768
4.

Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.

Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M.

J Heart Lung Transplant. 2007 Jul;26(7):681-6.

PMID:
17613397
5.

Primary graft dysfunction and long-term pulmonary function after lung transplantation.

Whitson BA, Prekker ME, Herrington CS, Whelan TP, Radosevich DM, Hertz MI, Dahlberg PS.

J Heart Lung Transplant. 2007 Oct;26(10):1004-11.

PMID:
17919620
6.

Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).

Fisher AJ, Wardle J, Dark JH, Corris PA.

J Heart Lung Transplant. 2002 Nov;21(11):1206-12.

PMID:
12431494
7.

Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?

Jackson CH, Sharples LD, McNeil K, Stewart S, Wallwork J.

J Heart Lung Transplant. 2002 Jun;21(6):658-66.

PMID:
12057699
8.

Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.

Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, Savik K, Reinsmoen NL.

Transplantation. 2002 Sep 27;74(6):799-804.

PMID:
12364858
9.

Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.

Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA.

Ann Thorac Surg. 1995 Nov;60(5):1341-6; discussion 1346-7.

PMID:
8526624
10.

Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung transplant recipients.

Nathan SD, Barnett SD, Wohlrab J, Burton N.

J Heart Lung Transplant. 2003 Apr;22(4):427-32.

PMID:
12681420
11.

Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.

Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Hutcheon MA, Keshavjee S.

J Heart Lung Transplant. 2011 Jul;30(7):735-42. doi: 10.1016/j.healun.2011.01.712. Epub 2011 Mar 17.

PMID:
21419659
12.

Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.

Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA.

Am J Respir Crit Care Med. 2008 May 1;177(9):1033-40. doi: 10.1164/rccm.200706-951OC. Epub 2008 Feb 8.

PMID:
18263803
13.

Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation.

Tamm M, Sharples L, Higenbottam T, Stewart S, Wallwork J.

Transpl Int. 1996;9 Suppl 1:S299-302.

PMID:
8959850
15.

Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation.

Atkins BZ, Petersen RP, Daneshmand MA, Turek JW, Lin SS, Davis RD Jr.

Ann Thorac Surg. 2010 Nov;90(5):1622-8. doi: 10.1016/j.athoracsur.2010.06.089.

PMID:
20971276
16.

Impact of lung transplant operation on bronchiolitis obliterans syndrome in patients with chronic obstructive pulmonary disease.

Hadjiliadis D, Chaparro C, Gutierrez C, Steele MP, Singer LG, Davis RD, Waddell TK, Hutcheon MA, Palmer SM, Keshavjee S.

Am J Transplant. 2006 Jan;6(1):183-9.

17.

Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.

Luckraz H, Sharples L, McNeil K, Wreghitt T, Wallwork J.

J Heart Lung Transplant. 2003 Mar;22(3):287-91.

PMID:
12633696
18.

Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches.

van den Berg JW, Hepkema BG, Geertsma A, Koëter GH, Postma DS, de Boer WJ, Lems SP, van der Bij W.

Transplantation. 2001 Feb 15;71(3):368-73.

PMID:
11233895
19.

Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.

Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T.

Transplantation. 2008 Jan 15;85(1):36-41. doi: 10.1097/01.tp.0000295981.84633.bc.

PMID:
18192909
20.

Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.

Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J.

Transplantation. 1996 Feb 27;61(4):560-6.

PMID:
8610381

Supplemental Content

Support Center